ZURICH, July 16 (Reuters) - The Swiss blue-chip SMI was seen opening 0.1 percent higher at 8,870 points on Monday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks.
* Roche – said on Friday it had received FDA clearance for the expanded use of its Elecsys B.R.A.H.M.S PCT Assay
* Schindler chairman Silvio Napoli told Finanz und Wirtschaft he would like the lift-maker to go private, saying financial reporting has become more complex and exiting the bourse would give the company more freedom. But the company has no plans at present.
* Vaudoise Assurance said Jan Ellbrock has started his role as chief transformation officer and member of the company’s managing board.
* Cassiopea said results of a trial for its topical antiandrogen Clascoterone had shown very positive results.
* Rieter Holding - Verasion Capital said it had acquired a 3.03 percent stake in Rieter Holding.
Swiss National Bank releases sight deposits at 0800 GMT
Reporting by Zurich newsroom